Global oral vaccines market is undergoing a steady yet strategically significant expansion as healthcare systems prioritize needle-free immunization, large-scale disease prevention, and improved patient compliance. Valued at USD 2.365 billion in 2024, the market is projected to grow from USD 2.48 billion in 2025 to USD 3.227 billion by 2031, registering a CAGR of 4.7% during the forecast period. This growth trajectory reflects the rising reliance on oral immunization programs, particularly across pediatric and public health applications worldwide.

Access the full report -https://www.24lifesciences.com/oral-vaccines-market-7377